Gut-kidney interaction reinforces dapagliflozin-mediated alleviation in diabetic nephropathy
American Journal of Physiology-Cell Physiology · 01.02.2025 · 328 (2) · C452-C466
DOI: 10.1152/ajpcell.00651.2024 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, erschienen am 01.02.2025. Verfasst von Yinhua Ni und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, China. Hauptthemen laut MEDLINE: Benzhydryl Compounds, Glucosides, Diabetic Nephropathies, Gastrointestinal Microbiome. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Fund from Zhejiang Wuhu Biotechnology Co., Ltd, National Natural Science Foundation of China (NSFC), the Huadong Medicine Joint Funds of the Zhejiang Provincial Natural Science Foundation of China.
Abstract (Originalsprache)
We demonstrated that dapagliflozin administration alleviated renal inflammation and fibrosis in vivo and in vitro, along with reshaping the gut microbiota composition and altering levels of key microbial metabolites, including argininosuccinic acid (ASA) and palmitic acid (PA), while increasing S-allylcysteine (SAC). Importantly, the genera Muribaculaceae and Desulfovibrionaceae emerged as pivotal microbial genera mediating the protective effects of dapagliflozin against diabetic nephropathy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, China.
- Laboratory of Food Biochemistry, Department of Applied Biological Chemistry, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, Japan.
- Department of Nephrology, First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, China.
- Zhejiang Key Laboratory of Research and Translation for Kidney Deficiency-Stasis-Turbidity Disease, Hangzhou, Zhejiang, China.
Förderung
- The Fund from Zhejiang Wuhu Biotechnology Co., Ltd
- National Natural Science Foundation of China (NSFC)
- the Huadong Medicine Joint Funds of the Zhejiang Provincial Natural Science Foundation of China
- the Construction of Key Projects by Zhejiang Provincial Ministry
- the Key Project of Scientific Research Foundation of Chinese Medicine
- the "Pioneer" and "Leading Goose" R&D Program of Zhejiang
- Huatong Guokang Medical Research Project
- MOST | National Key Research and Development Program of China (NKPs)
Zitieren
APA
Ni, Y., Du, H., Ke, L., Zheng, L., Nan, S., Ni, L., Pan, Y., Fu, Z., He, Q., & Jin, J. (2025). Gut-kidney interaction reinforces dapagliflozin-mediated alleviation in diabetic nephropathy. American Journal of Physiology-Cell Physiology, 328(2), C452-C466. https://doi.org/10.1152/ajpcell.00651.2024
Vancouver
Ni Y, Du H, Ke L, Zheng L, Nan S, Ni L, et al. Gut-kidney interaction reinforces dapagliflozin-mediated alleviation in diabetic nephropathy. American Journal of Physiology-Cell Physiology. 2025;328(2):C452-C466. doi:10.1152/ajpcell.00651.2024
BibTeX
@article{Ni2025,
author = {Ni, Yinhua and Du, Haimei and Ke, Lehui and Zheng, Liujie and Nan, Sujie and Ni, Liyang and Pan, Yuxiang and Fu, Zhengwei and He, Qiang and Jin, Juan},
title = {Gut-kidney interaction reinforces dapagliflozin-mediated alleviation in diabetic nephropathy},
journal = {American Journal of Physiology-Cell Physiology},
year = {2025},
volume = {328},
number = {2},
pages = {C452--C466},
doi = {10.1152/ajpcell.00651.2024}
}
EUVIMED